Specialty
Certifications
Anatomic & Clinical Pathology
Clinical Focus
- Anal Cancer
- Barrett's Esophagus
- Celiac Disease
- Colon Polyps
- Colorectal Cancer
- Colorectal Resection
- Crohn's Disease
- Diverticulitis
- Esophageal Cancer
- Esophagectomy
- Gastrectomy
- Gastritis
- Inflammatory Bowel Disease
- Ischemic Bowel Disease
- Peptic Ulcer
- Small Bowel Resection
- Squamous Cell Carcinoma
- Stomach Cancer
- Ulcerative Colitis
- Upper GI Endoscopy
Education
MD, Univ of Miami-School of Medicine
Ph.D., Feinberg Graduate School Weizmann Institute of Science
Hospital for Sick Children
Research PathologyM.D., University of Miami School of Medicine
Mount Sinai School of Medicine
Anatomic and Clinical PathologySt. Mark's Hospital
Gastrointestinal PathologyResidency, Pathology
Mount Sinai Hospital
Biography
Clinical Interest
Gastrointestinal pathology, general surgical pathology, and diagnostic immunopathology.
Publications
Bansal R, Harpaz N, Itzkowitz SH, Ullman T, Matula S, Bodian C, Hossain S. Histological Inflammation is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort Study. Gastroenterology 2007; 133: 1099-1105.
Fukata M, Chen A, Vamadevan AS, Cohen J, Breglio K, Krishnareddy S, Abreu MT, Harpaz N, Dannenberg AJ, Subbaramaiah K, Cooper HS, Itzkowitz SH, Xu R. Toll-like receptor-4 (TLR4) promotes the development of colitis-associated colorectal tumors. Gastroenterology 2007; 133: 1869-1881.
Frank DN, St. Amand AL, Pace NR, Boedeker EC, Harpaz N, Feldman RA. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Nat Acad Sci 2007; 104: 13780-13788.
Harpaz N. Neoplastic Precursors of colorectal cancer in inflammatory bowel disease. Gastro Clin N Am 2007; 36: 901-926.
Harpaz N, Levi GS. Intestinal low-grade tubuloglandular adenocarcinoma in inflammatory bowel disease. Am J Surg Pathol 2006; 30: 1022-1029.
Clinical Trials
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Harpaz did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Annenberg Building Floor 15 Room 38
1468 Madison Avenue
New York, NY 10029
Annenberg Building Floor 15th Floor Room Room 32
1468 Madison Avenue
New York, NY 10029
Fax: 212-289-2899
